Hydralazine Hydrochloride recalls
Hydralazine Hydrochloride products have been recalled 3 times, most recently on 3 Jan 2024. The recalling company is usually Mckesson Medical Surgical. The most common reason is packaging defects.
Total recalls3since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 3 Jan 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why hydralazine hydrochloride is recalled
Companies
Product types
By year
All hydralazine hydrochloride recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | HydrALAZINE Hydrochloride Tablets, USP, 25 mg recalledHydralazine Hydrochloride | Cardinal Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | hydrALAZINE Hydrochloride Injection, USP, 20 mg/mL Single Dose Vial recalledHydralazine Hydrochloride | Mckesson Medical Surgical | Packaging Defects | Nationwide |
| Drug | CLASS III | Hydralazine Hydrochloride Injection, USP, 20 mg/mL fill recalledHydralazine Hydrochloride | Fresenius Kabi USA | Packaging Defects | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.